Gene Disease Score gda Association Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 611
Gene Symbol: OPN1SW
OPN1SW
CUI: C0003125
Disease: Anorexia Nervosa
Anorexia Nervosa
0.060 Biomarker BEFREE Based on these results, CBT-E seems suitable for adolescent patients with anorexia nervosa seeking treatment in a real-world clinical setting. 31199022

2019

Entrez Id: 611
Gene Symbol: OPN1SW
OPN1SW
CUI: C0003125
Disease: Anorexia Nervosa
Anorexia Nervosa
0.060 Biomarker BEFREE Therefore, classifying individuals as "severe and enduring" appears to lack clinical utility in CBT-E. Clinicians should continue to administer evidence-supported treatments such as CBT-E for patients with AN, regardless of duration or severity of AN illness.(PsycINFO Database Record 30035586

2018

Entrez Id: 611
Gene Symbol: OPN1SW
OPN1SW
CUI: C0003125
Disease: Anorexia Nervosa
Anorexia Nervosa
0.060 Biomarker BEFREE Hence, we compared short- and long-term outcomes of inpatient enhanced cognitive-behavioural therapy (CBT-E) in patients with anorexia nervosa who had and had not suffered sexual abuse. 28927864

2018

Entrez Id: 611
Gene Symbol: OPN1SW
OPN1SW
CUI: C0003125
Disease: Anorexia Nervosa
Anorexia Nervosa
0.060 GeneticVariation BEFREE Our data suggest that the DSM-5 severity specifiers for anorexia nervosa may have limited clinical utility in predicting treatment outcomes of CBT-E. 30059831

2018

Entrez Id: 611
Gene Symbol: OPN1SW
OPN1SW
CUI: C0003125
Disease: Anorexia Nervosa
Anorexia Nervosa
0.060 Biomarker BEFREE Within the Anorexia Nervosa Treatment of Out Patients (ANTOP) study, the largest multisite outpatient intervention trial in anorexia nervosa (AN) to date, manualised enhanced cognitive-behavioural therapy (CBT-E) was offered as one treatment modality. 30380658

2018

Entrez Id: 611
Gene Symbol: OPN1SW
OPN1SW
CUI: C0003125
Disease: Anorexia Nervosa
Anorexia Nervosa
0.060 Biomarker BEFREE These findings suggest that inpatient CBT-E is well accepted by patients with AN, and could also be a viable and promising treatment for those with SE-AN. 27863331

2017